Medical News

RSS

Wired Magazine features Pyng's MAT Tourniquet as one of the Top 10 Products Designed for Good

Pyng Medical Corp.'s (the "Company") (TSX VENTURE:PYT) MAT® Tourniquet is being featured in the October edition of Wired UK Magazine as one of the "Top 10 Designs for Good."

4 Sep 2009

Drive to collect unused prescription drugs starts on October 3

In an effort to keep unused prescription drugs out of the hands of pre-teens and teenagers, DDN executive Joe Otto enlisted the support of Menomonee Falls Police Chief Anna Ruzinski, Community Memorial Hospital, and his company. As a result, Community Memorial Hospital will serve as collection site when Waukesha County kicks off its first drug collection program on October 3.

4 Sep 2009

Filing and review of belatacept's license application accepted by the FDA

Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the company’s submission of a biologic license application for belatacept, which is in ongoing phase III development for use in kidney transplantation.

4 Sep 2009

Online news conferrence to announce findings from the Census Bureau's annual report

The U.S. Census Bureau will hold an online news conference to announce the findings from its annual report: Income, Poverty, and Health Insurance Coverage in the United States: 2008. This report contains the official national findings from the Current Population Survey (CPS).

4 Sep 2009

Researchers identify new molecular switch that produces cancer cells

A team of Syracuse University researchers discovered a second molecular switch within the Mixed Lineage Leukemia protein complex that they believe could be exploited to prevent the overproduction of abnormal cells that are found in several types of cancer, including leukemia.

4 Sep 2009

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.

4 Sep 2009

Dr Lluis Quintana-Murci from the Institut Pasteur in France honoured with the Debiopharm Life Sciences Award

Debiopharm Group, SA (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today presented the 'Debiopharm Life Sciences Award' to Dr Lluis Quintana-Murci from the Institut Pasteur in France, for his outstanding innovative research in the emerging field of evolutionary genetics of infection.

4 Sep 2009

No performance enhancing effect of quercetin seen, according to a study

The antioxidant quercetin is increasingly being marketed as a supplement that boosts athletic performance, but a new University of Georgia study finds that it is no better than a placebo.

4 Sep 2009

Real American Brands to start medical transportation business

Real American Brands, Inc. (PINKSHEETS: RLAB) announced today that the company has approved plans to pursue and operate an emergency and non-emergency health services transportation division, to be developed in close consultation with transport and medical personnel who have broad experience in the field.

4 Sep 2009

NAS selected for the CAAT Recognition Award for 2009

The Center for Alternatives to Animal Testing (CAAT) at the Johns Hopkins Bloomberg School of Public Health has selected the National Academy of Sciences (NAS) and the authors of the groundbreaking report, Toxicity Testing in the 21st Century: A Vision and a Strategy, to receive the CAAT Recognition Award for 2009. The award was presented on September 3 at the 7th World Congress on Alternatives and Animal Use in the Life Sciences in Rome.

4 Sep 2009

The 2009 Heart and Stroke Foundation Report on health of Ontario's kids

In 1998, the Heart and Stroke Foundation's Report Card on Canada's Kids took a hard look at the heart health of Canadian children aged 6-12. More than 10 years later, the Foundation shines the spotlight on Ontario's kids - and will be issuing its own Report Card on the heart health of this young cohort.

4 Sep 2009

VA tries to keep up with surge of need

The Department of Veterans Affairs is experiencing a surge of treatment requests and disability claims as soldiers return from Iraq and Afghanistan, overwhelming VA clinics.

4 Sep 2009

TV awareness campaign to dispel the negative stigma regarding mental illness

The National Alliance on Mental Illness (NAMI) Michigan is launching a television awareness campaign this holiday weekend designed to dispel the negative stigma associated with mental illness.

4 Sep 2009

Advanced Nutrients' controversial banner for protesting against hydroponic hijacking

On the day that the Man burns at the legendary Nevada Burning Man event this year in the Black Rock Desert, partiers will see a giant marijuana bud banner flying overhead.

4 Sep 2009

New Promega GoTaq qPCR Master Mix features increased reliability

Now real-time PCR methods can detect even smaller changes and rare events with the new Promega GoTaq qPCR Master Mix. The new GoTaq qPCR Master Mix frequently delivers earlier cycle thresholds than SYBR Green I. The advanced functionality gives scientists both increased reliability and reproducibility compared to the performance of existing real-time reagent systems.

4 Sep 2009

$NEI awards grant to Vivakor for developing a digital photo-refractor$

NEI awards grant to Vivakor for developing a digital photo-refractor

Vivakor, Inc. announced that the National Institutes of Health-National Eye Institute has awarded a grant to Vivakor, Inc. in Coralville, IA through the Small Business Innovation Research Awards.

4 Sep 2009

Phase III clinical trial results of XIAFLEX published in a journal

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products today announced results of the pivotal CORD I Phase III clinical trial of XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class biologic for the nonsurgical treatment of Dupuytren's disease, was published in today's edition of the New England Journal of Medicine.

4 Sep 2009

South Dakota Biotech Association to present the 4th Annual South Dakota Biotechnology Summit

Investing in Biotechnology for Life, Food and Energy,” is the theme for the 4th Annual South Dakota Biotechnology Summit and Annual Meeting on Thursday, September 17, 2009. This annual event is presented by the South Dakota Biotech Association and will be held at the Ramkota Hotel, Rushmore Room in Sioux Falls, SD.

4 Sep 2009

94-year-old crusader seeks ban on trans fats in the American diet

Fred Kummerow, a 94-year-old University of Illinois veterinary biosciences professor emeritus who still conducts research on the health effects of trans fats in the diet, filed the petition with the FDA last month. The petition is now posted on the FDA Web site, and public comments are invited. (See below for information on viewing the petition and making a comment.)

4 Sep 2009

Strata brands of Foley catheters launched by Rochester Medical Corporation

Rochester Medical Corporation (Nasdaq: ROCM) today announced the introduction of its Strata brands of Foley catheters. This new Foley product line features proprietary comfort layered technology. The company's StrataSI(TM) catheter is all-silicone, while the StrataNF(TM) version includes a nitrofurazone anti-infective matrix within the silicone.

4 Sep 2009